FALLS CHURCH, Va., Aug. 1, 2019 /PRNewswire-PRWeb/ -- Real World Evidence and Data: A Tufts Study of 30 Pharma Companies
The CSDD investigated 30 biopharmaceutical companies' use of RWD to generate evidence and showed the top measures for using RWE for return on investment, among other findings. It concluded that expanding the use of RWE in regulatory decision-making and increasing sponsors' use of RWD will fill critical gaps related to drug development and safety. The speakers will walk attendees through the study's important takeaways.
Mary Jo Lamberti, PhD, a Tufts University professor and associate director of sponsored research at the CSDD, along with Francis Kendall, a 30-year pharmaceutical industry veteran and senior director at Cytel where he is an instrumental player in the company's Real World Analytics team, will discuss cases of what is being done with RWE and RWD.
Based on their knowledge, and using several recent case studies, Dr. Lamberti and Mr. Kendall will share valuable information on:
Understand the critical factors needed to consider in using RWE, and gain insight into the current and planned uses of RWE to support development and post-approval safety studies.
Interested in registering multiple sites? Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally to learn about our special multisite discount.
Webinar Details: Real World Evidence and Data: A Tufts Study of 30 Pharma Companies An FDAnews Webinar Thursday, Aug. 15, 2019 • 1:30-3:00 p.m. EDT https://www.fdanews.com/realworldevidenceanddatatuftsstudy?hittrk=19801VOCUS [https://www.fdanews.com/realworldevidenceanddatatuftsstudy __title__ Real World Evidence]
Tuition: $287 per site
Easy Ways to Register: Online: https://www.fdanews.com/realworldevidenceanddatatuftsstudy By phone: 888-838-5578 or 703-538-7600
About FDAnews: FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.
Subscribe to our Free Newsletters!